BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20334540)

  • 1. A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect.
    Hua S; Yang H; Wang A
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1106-14. PubMed ID: 20334540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adsorption characteristics of Congo Red onto the chitosan/montmorillonite nanocomposite.
    Wang L; Wang A
    J Hazard Mater; 2007 Aug; 147(3):979-85. PubMed ID: 17349744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug release behavior of chitosan-montmorillonite nanocomposite hydrogels following electrostimulation.
    Liu KH; Liu TY; Chen SY; Liu DM
    Acta Biomater; 2008 Jul; 4(4):1038-45. PubMed ID: 18337198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design of biodegradable ofloxacin-based core-shell microspheres: influence of the formulation parameters on in vitro characterization.
    Sezer AD; Akbuğa J
    Pharm Dev Technol; 2012; 17(1):118-24. PubMed ID: 20977313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery.
    Cai J; Zhang Y; Du W; Nan K
    J Control Release; 2011 Nov; 152 Suppl 1():e70-1. PubMed ID: 22195935
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and characterization of a novel chitosan/montmorillonite/hydroxyapatite nanocomposite for bone tissue engineering.
    Katti KS; Katti DR; Dash R
    Biomed Mater; 2008 Sep; 3(3):034122. PubMed ID: 18765898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation and controlled drug release studies of nanohybrids based on chitosan-g-lactic acid and montmorillonite.
    Depan D; Kumar AP; Singh RP
    Acta Biomater; 2009 Jan; 5(1):93-100. PubMed ID: 18796355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
    Wang LY; Gu YH; Su ZG; Ma GH
    Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, and antimicrobial activity of quaternized chitosan/organic montmorillonite nanocomposites.
    Wang X; Du Y; Yang J; Tang Y; Luo J
    J Biomed Mater Res A; 2008 Feb; 84(2):384-90. PubMed ID: 17618481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FT-IR study of montmorillonite-chitosan nanocomposite materials.
    Paluszkiewicz C; Stodolak E; Hasik M; Blazewicz M
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Aug; 79(4):784-8. PubMed ID: 20864391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan microparticle preparation for controlled drug release by response surface methodology.
    Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
    J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Layered bionanocomposites as carrier for procainamide.
    Kevadiya BD; Joshi GV; Bajaj HC
    Int J Pharm; 2010 Mar; 388(1-2):280-6. PubMed ID: 20074630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release formulation of ranitidine-containing montmorillonite and Eudragit E-100.
    Joshi GV; Kevadiya BD; Bajaj HC
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1046-53. PubMed ID: 20545505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activity of novel chitosan/cloisite 10A nanocomposite: Preparation, optimization, characterization and drug delivery behavior.
    Rou J; Mohapatra R; Sahoo SK
    Pak J Pharm Sci; 2016 Jul; 29(4):1145-50. PubMed ID: 27393427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan based hydrogel microspheres as drug carriers.
    Vodná L; Bubeníková S; Lacík I; Chorvát D; Bakos D
    Macromol Biosci; 2007 May; 7(5):629-34. PubMed ID: 17477445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate/quaternized carboxymethyl chitosan/clay nanocomposite microspheres: preparation and drug-controlled release behavior.
    Liu B; Luo J; Wang X; Lu J; Deng H; Sun R
    J Biomater Sci Polym Ed; 2013; 24(5):589-605. PubMed ID: 23565870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of uniform-sized chitosan microspheres containing insulin by membrane emulsification and a two-step solidification process.
    Wang LY; Gu YH; Zhou QZ; Ma GH; Wan YH; Su ZG
    Colloids Surf B Biointerfaces; 2006 Jul; 50(2):126-35. PubMed ID: 16787743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.
    Anal AK; Stevens WF; Remuñán-López C
    Int J Pharm; 2006 Apr; 312(1-2):166-73. PubMed ID: 16497452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of uniform-sized chitosan microspheres and application as carriers for protein drugs].
    Gu YH; Wang LY; Tan TW; Ma GH
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):150-5. PubMed ID: 16572856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and drug release property of tanshinone IIA loaded chitosan-montmorillonite microspheres.
    Luo C; Yang Q; Lin X; Qi C; Li G
    Int J Biol Macromol; 2019 Mar; 125():721-729. PubMed ID: 30552926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.